Evidence map›Paper›PMID 26121684›Full record

ReviewAdvanced healthcare materials2015

Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.

Sue Hyun Lee, Jung Bok Lee, Min Soo Bae, Daniel A Balikov, Amy Hwang, Timothy C Boire, Il Keun Kwon, Hak-Joon Sung, Jae Won Yang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advanced healthcare materials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Carbon Dots for the Treatment of Inflammatory Diseases: An Appraisal ofOxidative medicine and cellular longevity · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Folate-mediated chemotherapy and diagnostics: An updated review and outlook.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sue Hyun LeeDepartment of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Jung Bok LeeDepartment of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Min Soo BaeDepartment of Bioengineering, College of Engineering, University of Washington, Seattle, WA, 98195, USA.
Daniel A BalikovDepartment of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Amy HwangDepartment of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Timothy C BoireDepartment of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Il Keun KwonDepartment of Maxillofacial Biomedical Engineering and Institute of Oral Biology, School of Dentistry, Kyung Hee University, Seoul, 130-701, Republic of Korea.
Hak-Joon SungDepartment of Biomedical Engineering, School of Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
Jae Won YangDepartment of Pathology Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37235, USA.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Thermosensitive injectable polymer-based stem cell therapy for limb ischemiaR21EB019509 · NIBIB · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SUNG, HAK-JOON, YOUNG, PAMPEE P · 2015 to 2016
$433k
NIBIB NIH HHS R21 EB019509NIGMS NIH HHS T32 GM007347
6 · The paper itself

Abstract

Significant progress has been made in nanomedicine, primarily in the form of nanoparticles, for theranostic applications to various diseases. A variety of materials, both organic and inorganic, have been used to develop nanoparticles with promise to achieve improved efficacy in medical applications as well as reduced systemic side effects compared to current standard of care medical practices. In particular, this article highlights the recent development and application of nanoparticles for diagnosing and treating nephropathologies.

Indexed as

NanomedicineChitosanContrast MediaDendrimersDrug CarriersFerrosoferric OxideHumansKidney DiseasesLiposomesMagnetic Resonance ImagingNanoparticlesPolymersRadiographyChitosanContrast MediaDendrimersDrug CarriersFerrosoferric OxideLiposomesPolymersdrug deliverykidney diseasenanoparticlespodocyte

Identifiers

PMID26121684
PMCPMC4874338

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.